Evidence map›Paper›PMID 34068615›Full record

ArticleTropical medicine and infectious disease2021

Assessing the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Selected Health Facilities in Nairobi, Kenya.

Irene Mbithi, Pruthu Thekkur, Jeremiah Muhwa Chakaya, Elizabeth Onyango, Philip Owiti, Ngugi Catherine Njeri, Ajay M V Kumar, Srinath Satyanarayana, Hemant D Shewade, Mohammed Khogali and 4 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Lived experiences of tuberculosis patients accessing treatment during COVID-19 in Zimbabwe.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Effect of Coronavirus Disease 2019 Lockdowns on Identification of Advanced Human Immunodeficiency Virus Disease in Outpatient Clinics in Uganda.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  18. Article
  19. The in-hospital tuberculosis diagnostic cascade and early clinical outcomes among people living with HIV before and during the COVID-19 pandemic - a prospective multisite cohort study from Ghana.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Irene MbithiRespiratory Society of Kenya, Regent Court, Block A Suite A6 Hurlingham, Argwings Khodhek Road, Nairobi, Kenya.ORCID 0000-0001-7784-0604
Pruthu ThekkurInternational Union Against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France.ORCID 0000-0001-5257-5074
Jeremiah Muhwa ChakayaRespiratory Society of Kenya, Regent Court, Block A Suite A6 Hurlingham, Argwings Khodhek Road, Nairobi, Kenya.
Elizabeth OnyangoDivision of National TB, Leprosy and Lung Disease Programme, Ministry of Health, Afya House, Cathedral Road, PO Box 30016-00100, Nairobi, Kenya.
Philip OwitiDivision of National TB, Leprosy and Lung Disease Programme, Ministry of Health, Afya House, Cathedral Road, PO Box 30016-00100, Nairobi, Kenya.
Ngugi Catherine NjeriNational AIDS and STDs Control Programme, Ministry of Health, Afya House, Cathedral Road, PO Box 30016-00100, Nairobi, Kenya.
Ajay M V KumarInternational Union Against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France.
Srinath SatyanarayanaInternational Union Against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France.ORCID 0000-0002-5420-2551
Hemant D ShewadeInternational Union Against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France.
Mohammed KhogaliSpecial Programme for Research and Training in Tropical Disease (TDR), World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Rony ZachariahSpecial Programme for Research and Training in Tropical Disease (TDR), World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.ORCID 0000-0002-2915-9328
I D RusenVital Strategies, 100 Broadway 4th Floor, New York, NY 10005, USA.
Selma Dar BergerInternational Union Against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France.
Anthony D HarriesInternational Union Against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France.ORCID 0000-0001-6113-9741

Funding

Vital Strategies, USA 1234494C4397 docusaveWorld Health Organization 001
6 · The paper itself

Abstract

There was concern that the COVID-19 pandemic would adversely affect TB and HIV programme services in Kenya. We set up real-time monthly surveillance of TB and HIV activities in 18 health facilities in Nairobi so that interventions could be implemented to counteract anticipated declining trends. Aggregate data were collected and reported monthly to programme heads during the COVID-19 period (March 2020-February 2021) using EpiCollect5 and compared with monthly data collected during the pre-COVID period (March 2019-February 2020). During the COVID-19 period, there was an overall decrease in people with presumptive pulmonary TB (31.2%), diagnosed and registered with TB (28.0%) and in those tested for HIV (50.5%). Interventions to improve TB case detection and HIV testing were implemented from August 2020 and were associated with improvements in all parameters during the second six months of the COVID-19 period. During the COVID-19 period, there were small increases in TB treatment success (65.0% to 67.0%) and referral of HIV-positive persons to antiretroviral therapy (91.2% to 92.9%): this was more apparent in the second six months after interventions were implemented. Programmatic interventions were associated with improved case detection and treatment outcomes during the COVID-19 period, suggesting that monthly real-time surveillance is useful during unprecedented events.

Indexed as

antiretroviral therapyCOVID-19EpiCollect5HIVKenyaNairobioperational researchpresumptive tuberculosisTB treatment outcomestuberculosis

Identifiers

PMID34068615
PMCPMC8163186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.